PRESCRIPTION OPIOIDS: ARE OUR PAIN KILLERS KILLING OUR PATIENTS? PETER KRECKEL, RPH

Size: px

Start display at page:

Download "PRESCRIPTION OPIOIDS: ARE OUR PAIN KILLERS KILLING OUR PATIENTS? PETER KRECKEL, RPH"

Gyles Vernon Rose
7 years ago
Views:

1 PRESCRIPTION OPIOIDS: ARE OUR PAIN KILLERS KILLING OUR PATIENTS? PETER KRECKEL, RPH

PRESCRIPTION OPIOIDS: ARE OUR PAIN KILLERS KILLING ACTIVITY DESCRIPTION Prescription drug abuse is a huge problem, and this problem is climbing at a very rapid rate.

2 PRESCRIPTION OPIOIDS: ARE OUR PAIN KILLERS KILLING ACTIVITY DESCRIPTION Prescription drug abuse is a huge problem, and this problem is climbing at a very rapid rate. Opioid abuse costs the US over $72 billion annually in the United States. In fact, Americans consume 80% of the global world supply of opioids. This program will cover the history of US laws pertaining to approval of drugs, as well as the DEA's rules of enforcement. We will also cover the history of problematic drugs of abuse and strategies for dealing with their abuse potential. Professor Peter Kreckel will also give some "from pharmacist to pharmacist tips" on certain red flags that could clue you in to someone who is abusing prescription opioids. TARGET AUDIENCE The target audience for this activity is pharmacists, nurses and pharmacy technicians in hospital, community, and retail pharmacy settings. LEARNING OBJECTIVES After completing this activity, the pharmacist and nurse will be able to: Identify the history of United States laws that pertain to the approval of drugs and the DEA s role in their enforcement Outline the history of drugs with the potential for abuse and strategies for dealing with abuse potential Describe the role of the pharmacist and the drug wholesaler in the prevention of drug abuse as well as the profession's role in deterring diversion After completing this activity, the pharmacy technician will be able to: List laws that pertain to approval of drugs and their enforcement List prescription drugs that are commonly used for abuse OUR PATIENTS? ACCREDITATION PHARMACY PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. NURSING PharmCon, Inc. is approved by the California Board of Registered Nursing (Provider Number CEP 13649) and the Florida Board of Nursing (Provider Number ). Activities approved by the CA BRN and the FL BN are accepted by most State Boards of Nursing. CE hours provided by PharmCon, Inc. meet the ANCC criteria for formally approved continuing education hours. The ACPE is listed by the AANP as an acceptable, accredited continuing education organization for applicants seeking renewal through continuing education credit. For additional information, please visit Universal Activity No.: H05-P&T Credits: 1.25 contact hours (0.125 CEU) Release Date: July 24, 2014 Expiration Date: October 21, 2016 ACTIVITY TYPE Knowledge-Based, Home-Study Webinar FINANCIAL SUPPORT BY Pharmaceutical Education Consultants, Inc. 1

3 ABOUT THE AUTHOR Professor Pete Kreckel is a practicing retail pharmacist who works in Altoona Pennsylvania. Both he and his wife, Denise are 1981 graduates of the University of Pittsburgh School of Pharmacy. He has worked independent retail pharmacy for over 30 years. He has been teaching Pharmacology in the Physician Assistant program at St. Francis University since He has been a regular PharmCon favorite since 2008 covering topics of primary interest to the retail pharmacist. He was inducted into Pi Alpha the Physician Assistant honorary fraternity, and was named as Preceptor of the Year by the Pennsylvania Pharmacists Association for his dedicated work to the education of pharmacy students from Duquesne University, and from his alma mater the University of Pittsburgh. Peter Kreckel, RPh Adjunct Assistant Professor, Saint Francis University FACULTY DISCLOSURE It is the policy of PharmCon, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) and/or service(s) discussed in an educational activity. Peter Kreckel reports no actual or potential conflict of interest in relation to this activity. Peer review of the material in this CE activity was conducted to assess and resolve potential conflict of interest. Reviewers unanimously found that the activity is fair balanced and lacks commercial bias. Please Note: PharmCon, Inc. does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced and objective. Occasionally, authors may express opinions that represent their own viewpoint. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient or pharmacy management. Conclusions drawn by participants should be derived from objective analysis of scientific data presented from this monograph and other unrelated sources. 2

4 3

5 4

6 5

7 6

8 7

9 8

10 9

11 10

12 11

13 12

14 13

15 14

16 15

17 ACTIVITY TEST 1. Which of the following countries consumes 66% of the world s illegal drugs? A. India B. Italy C. United States D. Canada 2. Which of the following acts were passed in response to the Sulfanilamide Tragedy? A. Federal Food Drug and Cosmetic Act B. Kefauver Harris Drug Amendments C. Humphrey-Durham Act D. Antibiotic Analysis Act 3. Which of the following acts that required the drug manufacturers to prove efficacy of a drug before it was approved? A. Federal Food Drug and Cosmetic Act B. Kefauver Harris Drug Amendments C. Humphrey-Durham Act D. Food and Drug Act 4. Under what President of the United States was the Drug Enforcement Agency Created? A. Dwight Eisenhower B. John Kennedy C. Theodore Roosevelt D. Richard Nixon 5. Which of the following opiates is the MOST potent per milligram? A. Codeine B. Fentanyl C. Oxycodone D. Methadone 16

18 6. Which of the following opiates causes the greatest sensation of euphoria? A. Hydromorphone (Dilaudid) B. Oxymorphone (Opana) C. Methadone (Dolophine) D. Oxycodone (Oxycontin) 7. Which of the following opiates causes 30% of prescription painkiller deaths, even though it accounts for only 2% of the opiates filled? A. Hydromorphone (Dilaudid) B. Oxymorphone (Opana) C. Methadone (Dolophine) D. Oxycodone (Oxycontin) 8. Which of the following drug companies developed the drug diamorphine from morphine? A. Bayer and Company B. Eli Lilly and Company C. Boehringer Ingelheim D. Hoechst and Company 9. Which is the maximum published dose for oxycodone (combined extended release and immediate release) A. 320mg per day B. 480mg per day C. 720mg per day D. There are no published ceilings for oxycodone 10. Which of the following is NOT considered to be a red flag by the Drug Enforcement Agency? A. A patient getting oxycodone (Roxicodone) plus Fentanyl patch B. A patient getting oxycodone ER (Ocycontin) plus Dextroamphetamine (Dextrostat) C. A patient carisoprodol (Soma) plus hydrocodone (Vicodin) plus alprazolam (Xanax) D. Multiple patients with a common street address Please submit your final responses on freece.com. Thank you. 17

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES ACTIVITY DESCRIPTION